Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms.

S C Risch

    Biological Psychiatry
    |October 1, 1982
    PubMed
    Summary

    Depressed patients show higher beta-endorphin levels in morning plasma and increased release when stimulated. These findings suggest beta-endorphin may serve as a biological marker for depression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Charleston Antidepressant Drug Interactions Surveillance Program (CADISP).

    Psychopharmacology bulletin·2002
    Same author

    Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance.

    The Journal of neuropsychiatry and clinical neurosciences·2001
    Same author

    A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates.

    Neurocase·2001
    Same author

    Lack of significant changes on magnetic resonance scans before and after 2 weeks of daily left prefrontal repetitive transcranial magnetic stimulation for depression.

    The journal of ECT·2001
    Same author

    Repetitive transcranial magnetic stimulation: perspectives for application in the treatment of bipolar and unipolar disorders.

    Bipolar disorders·2001
    Same author

    A controlled trial of daily left prefrontal cortex TMS for treating depression.

    Biological psychiatry·2000

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Endocrinology

    Background:

    • Altered beta-endorphin levels are implicated in mood disorders.
    • Cholinergic system dysfunction is hypothesized in depression.

    Purpose of the Study:

    • To investigate plasma beta-endorphin concentrations in depressed patients.
    • To examine physostigmine-stimulated beta-endorphin release in depression.

    Main Methods:

    • Measured morning plasma beta-endorphin immunoreactivity.
    • Assessed physostigmine-stimulated beta-endorphin release.
    • Compared depressed patients with healthy and non-affective psychiatric controls.

    Main Results:

    • Significantly higher plasma beta-endorphin levels in depressed patients.
    • Significantly greater physostigmine-stimulated beta-endorphin release in depressed patients.
    • First evidence for elevated plasma beta-endorphin in depression.

    Conclusions:

    • Elevated plasma beta-endorphin may be a biological marker for depression.
    • Findings support cholinergic supersensitivity in depression.
    • Cholinergically stimulated beta-endorphin release could indicate state or trait markers for depression.

    Related Experiment Videos